Abstract:OBJECTIVE:There have been no objective assessments to determine whether boys with MECP2 duplication have autism or whether female carriers manifest phenotypes. This study characterizes the clinical and neuropsychiatric phenotypes of affected boys and carrier females. METHODS:Eight families (9 males and 9 females) with MECP2 duplication participated. A detailed history, physical examination, electroencephalogram, developmental evaluation, Autism Diagnostic Observation Schedule, and Autism Diagnostic Interview-Revised were performed for each boy. Carrier females completed the Symptom Checklist-90-R, Wechsler Abbreviated Scale of Intelligence, Broad Autism Phenotype Questionnaire, and detailed medical and mental health histories. Size and gene content of each duplication were determined by array comparative genome hybridization. X-chromosome inactivation patterns were analyzed using leukocyte DNA. MECP2 and IRAK1 RNA levels were quantified from lymphoblast cell lines, and western blots were performed to assess MeCP2 protein levels. RESULTS:All of the boys demonstrated mental retardation and autism. Poor expressive language, gaze avoidance, repetitive behaviors, anxiety, and atypical socialization were prevalent. Female carriers had psychiatric symptoms, including generalized anxiety, depression, and compulsions that preceded the birth of their children. The majority exhibited features of the broad autism phenotype and had higher nonverbal compared to verbal reasoning skills. INTERPRETATION:Autism is a defining feature of the MECP2 duplication syndrome in boys. Females manifest phenotypes despite 100% skewing of X-inactivation and normal MECP2 RNA levels in peripheral blood. Analysis of the duplication size, MECP2 and IRAK1 RNA levels, and MeCP2 protein levels revealed that most of the traits in affected boys are likely due to the genomic region spanning of MECP2 and IRAK1. The phenotypes observed in carrier females may be secondary to tissue-specific dosage alterations and require further study. Ann Neurol 2009;66:771-782.

Genetic analysis of a pedigree with MECP2 duplication syndrome in China

Chromosome Xq28 duplication encompassing MECP2: Clinical and molecular analysis of 16 new patients from 10 families in China.

Clinical and Molecular Genetic Characterization of Familial MECP2 Duplication Syndrome in a Chinese Family

MECP2 duplication syndrome in a Chinese family

Advance in research on MRCP2 duplication syndrome

Combined MECP2 duplication syndrome and ADNP syndrome in a Chinese boy: a case report and literature review

Diagnosis of MECP2 duplication syndrome with molecular genetic techniques

Lack of MECP2 Gene Transcription on the Duplicated Alleles of Two Related Asymptomatic Females with Xq28 Duplications and Opposite X‐chromosome Inactivation Skewing

A Case Report of Chinese Brothers with Inherited MECP2-containing Duplication: Autism and Intellectual Disability, but Not Seizures or Respiratory Infections

[Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with co-morbid Ornithine carbamoyl transferase deficiency and MECP2 duplication syndrome]

MECP2 and the biology of MECP2 duplication syndrome

Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome.

MECP2 Duplications in Symptomatic Females: Report on 3 Patients Showing the Broad Phenotypic Spectrum

MECP2 duplication syndrome initially misdiagnosed as cerebral palsy: a case report

Molecular Genetic Study of MECP2 Gene for a Patient with Typical Rett Syndrome

Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching.

Analysis of the Parental Origin of MECP2 Mutations in Patients with Rett Syndrome

Gut microbiome and metabolic profiles of mouse model for MeCP2 duplication syndrome

MECP2 Gene Mutation Analysis in Chinese Patients with Rett Syndrome

Familial Cases and Male Cases with MECP2 Mutations

MECP2-related disorders while gene-based therapies are on the horizon